These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 27193795

  • 1. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ, Chen WX, Wu DS, Zhang WY, Zheng LR.
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N.
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [Abstract] [Full Text] [Related]

  • 3. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K.
    Cancer Imaging; 2018 Feb 27; 18(1):8. PubMed ID: 29486800
    [Abstract] [Full Text] [Related]

  • 4. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.
    Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Fujita N, Kubo Y, Aishima S, Shirabe K, Yoshiura T, Honda H.
    Diagn Interv Radiol; 2015 Feb 27; 21(2):96-104. PubMed ID: 25698097
    [Abstract] [Full Text] [Related]

  • 5. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U.
    Eur Radiol; 2020 Nov 27; 30(11):5992-6002. PubMed ID: 32500195
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY, Lee JM, Choi SH, Kim SH, Lee JY, Kim SW, Han JK, Choi BI.
    J Comput Assist Tomogr; 2006 Nov 27; 30(1):18-24. PubMed ID: 16365567
    [Abstract] [Full Text] [Related]

  • 8. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI.
    AJR Am J Roentgenol; 2007 Dec 27; 189(6):1428-34. PubMed ID: 18029881
    [Abstract] [Full Text] [Related]

  • 9. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma.
    Jung AY, Lee JM, Choi SH, Kim SH, Lee JY, Kim SW, Han JK, Choi BI.
    J Comput Assist Tomogr; 2006 Dec 27; 30(2):173-81. PubMed ID: 16628028
    [Abstract] [Full Text] [Related]

  • 10. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M, Piscaglia F, Vavassori S, Galassi M, Sangiovanni A, Venerandi L, Forzenigo LV, Golfieri R, Bolondi L, Colombo M.
    J Hepatol; 2013 Jun 27; 58(6):1188-93. PubMed ID: 23485522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD, Ruan SM, Liang JY, Yang Z, Shen SL, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W.
    World J Gastroenterol; 2018 Sep 07; 24(33):3786-3798. PubMed ID: 30197484
    [Abstract] [Full Text] [Related]

  • 13. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI.
    Eur Radiol; 2016 Jun 07; 26(6):1808-17. PubMed ID: 26373763
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.